Isoquinolinone derivatives as NK3 antagonists

Details for Australian Patent Application No. 2009239990 (hide)

Owner H. Lundbeck A/S

Inventors Khanzhin, Nikolay; Juhl, Karsten; Nielsen, Soren Moller; Simonsen, Klaus Baek

Agent Spruson & Ferguson

Pub. Number AU-A-2009239990

PCT Pub. Number WO2009/130240

Priority PCT/ DK2008/050092 24.04.08 DK

Filing date 22 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 217/26 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4725 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/130240 Priority application(s): WO2009/130240

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009240006-Tat protein for preventing or treating AIDS

2009239988-Method for improving the storage stability of aqueous composite particle dispersions